2/09/2024

カンシノ・バイオロジクス(康希諾生物股分公司)が自社の新型コロナワクチンをエンガチョ!

China's CanSino Sinks on Dropping Covid-19 Vaccine Arm From Financial Reports
LIN ZHIYIN
DATE: FEB 05 2024/ SOURCE: YICAI

(Yicai) Feb. 5 -- Shares in CanSino Biologics slumped today after the Chinese pharma giant said that it will no longer include its Covid-19 jab making subsidiary in its financial statements, a move which will no doubt shield the company from slumping sales of its Covid-19 vaccines.

CanSino’s mainland-listed stock [SHA: 688185] plunged 7.7 percent to finish at CNY46.06 (USD6.40), while its Hong Kong-traded shares [HKG: 6185] closed down 2.8 percent at HKD15.50 (USD2).
CanSino no longer owns over half the voting rights and Board seats in CanSino SPH Biologics as its tie-up with Shanghai Biomedical Industrial Equity Investment Fund Partnership has expired, the Tianjin-based company said on Feb. 2. Although CanSino still owns equity in CanSino SPH, it is no longer in control of the firm.
CanSino SPH was set up in 2021 by CanSino, the Shanghai Biomedical Industrial Fund and Shanghai Pharmaceutical Holdings. At the time, CanSino invested CNY45 million (USD6.3 million) for a 45 percent stake. Later, it invested another CNY555 million to up its holdings to 49.8 percent.
The change will not have a big impact on CanSino’s financial status and business performance, it added.
There was a rumor in April last year that CanSino SPH had stopped producing Covid-19 vaccines altogether but CanSino said in November that the firm was running at a low volume.
CanSino's income has been badly hit since Covid-19 prevention measures were relaxed. The company racked up losses of CNY909 million (USD126 million) in 2022, a huge turnaround from the CNY1.9 billion (USD264.2 million) in net profit it reported in 2021.
And the firm is expecting its net losses to widen even further last year from 2022, by between 39.6 percent and 64.7 percent to between CNY1.3 billion (USD180.6 million) and CNY1.5 billion as sales of its Covid-19 jabs continue to tumble, according to its latest earnings forecast.

https://www.yicaiglobal.com/news/chinas-cansino-sinks-on-dropping-covid-19-vaccine-arm-from-financial-reports



吸入型の新型ウイルスワクチン、中国が緊急使用を承認 世界初
2022年9月6日

中国国家薬品監督管理局は、同国のカンシノ・バイオロジクス(康希諾生物股分公司)が開発した吸入型の新型コロナウイルスワクチンの緊急使用を承認した。カンシノ・バイオロジクスが4日に明らかにした。吸入型の新型ウイルスワクチンについて、使用が承認されたのは世界初。
吸入型ワクチン「Convidecia Air」には、注射型ワクチンと同様の成分が含まれる。新型ウイルスの遺伝子コードを無害なアデノウイルスを使って体内に入れ、ウイルスと戦う方法を覚えさせる。
カンシノ・バイオロジクスは、霧状のワクチンを一度吸入しただけで十分な予防効果が得られるとしている。
臨床試験では、ワクチン接種歴のある人の防御力をさらに高めることが示唆されている。

https://www.bbc.com/japanese/62804162



2022年12月20日火曜日

エアロジェンとCanSinoBIOが共同開発した世界初の吸入型COVID-19ワクチンがダメダメだった件

 

エアロジェンとCanSinoBIOが共同開発した世界初の吸入型COVID-19ワクチン、中国で初の公的ブースター接種

https://www.businesswire.com/news/home/20221113005057/ja/

 

CanSino Biologics Inc. Archives - Clarivate - Japan

Clarivate · https://clarivate.com › drug-company=cansin...
CanSino Biologics Inc. December 15, 2021. Ad5-nCoV (Convidecia™). Clarivate. 〒107-6118 東京都港区赤坂5丁目2番20号 赤坂パークビル18階. © 2022 Clarivate.


2014年12月9日火曜日

タカタ財団@卍ライン@赤坂パークビル

https://tokumei10.blogspot.com/2014/12/blog-post_14.html


ロイターがある赤坂パークビル・・・
エアロジェンJapanはBBCがある東京倶楽部ビルディング・・・
https://tokumei10.blogspot.com/2022/12/cansinobiocovid-19.html


イエールの岩崎さん…

、、、(爆wwwwwwwwwww

6 件のコメント:

  1. 東京倶楽部 藤島泰輔

    返信削除
  2. 武漢株アルファ株デルタ株等が流行ってるときは、吸入型の「弱毒生ワクチン」があれば接種したいとおもってた
    オミクロン流行りだしてから、これ実質生ワクチンだろって思ってるわ

    返信削除
  3. 確かクレディスイスもいたような 棒

    返信削除
  4. MoqHao Android Malware Evolves with Auto-Execution Capability
    https://thehackernews.com/2024/02/new-variant-of-moqhao-android-malware.html?m=1

    Threat hunters have identified a new variant of Android malware called MoqHao that automatically executes on infected devices without requiring any user interaction.

    "Typical MoqHao requires users to install and launch the app to get their desired purpose, but this new variant requires no execution," McAfee Labs said in a report published this week. "While the app is installed, their malicious activity starts automatically."

    The campaign's targets include Android users located in France, Germany, India, Japan, and South Korea.

    MoqHao, also called Wroba and XLoader (not to be confused with the Windows and macOS malware of the same name), is an Android-based mobile threat that's associated with a Chinese financially motivated cluster dubbed Roaming Mantis (aka Shaoye).

    ...

    返信削除
  5. 日本では高齢者のワクチン接種率が「下がる」現象が起きている
    https://twitter.com/odyssey3543/status/1726243991715491874

    返信削除
  6. 岩崎さんはドボンですね 半分詐欺みたいなもの

    返信削除